{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:25:01Z","timestamp":1791591901285,"version":"4.3.4"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioelectrochemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bioelechem.2022.108287","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T23:33:53Z","timestamp":1665099233000},"page":"108287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy"],"prefix":"10.1016","volume":"149","author":[{"given":"Christoph","family":"Pohling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith E.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bashkirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Stupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0787-0634","authenticated-orcid":false,"given":"Chirag B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.bioelechem.2022.108287_b0005","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.0702916104","article-title":"Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors","volume":"104","author":"Kirson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.bioelechem.2022.108287_b0010","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","article-title":"NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality","volume":"48","author":"Stupp","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.bioelechem.2022.108287_b0015","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioelechem.2022.108287_b0020","series-title":"Principles and Technologies for Electromagnetic Energy Based Therapies","first-page":"169","article-title":"6 - Treating solid tumors using tumor treating fields: an overview of the theory and practices","author":"Ze","year":"2022"},{"issue":"5","key":"10.1016\/j.bioelechem.2022.108287_b0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0030","doi-asserted-by":"crossref","unstructured":"Q.T. Ostrom, N. Patil, G. Cioffi, K. Waite, C. Kruchko, J.S. Barnholtz-Sloan, CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12 Suppl 2):iv1-iv9Epub 2020\/10\/31. doi: 10.1093\/neuonc\/noaa200. PubMed PMID: 33123732; PubMed Central PMCID: PMCPMC7596247.","DOI":"10.1093\/neuonc\/noaa200"},{"issue":"4","key":"10.1016\/j.bioelechem.2022.108287_b0035","first-page":"426","article-title":"Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis","volume":"8","author":"Regev","year":"2021","journal-title":"Neurooncol. Pract."},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020174","article-title":"Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF). A Review","volume":"11","author":"Fabian","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bioelechem.2022.108287_b0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11060-020-03540-6","article-title":"Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice","volume":"148","author":"Shi","year":"2020","journal-title":"J. Neurooncol."},{"issue":"11","key":"10.1016\/j.bioelechem.2022.108287_b0050","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.6004\/jnccn.2017.0166","article-title":"NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017","volume":"15","author":"Nabors","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.bioelechem.2022.108287_b0055","doi-asserted-by":"crossref","unstructured":"A. Kinzel, M. Ambrogi, M. Varshaver, E.D. Kirson, Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune((R)) System, Clin. Med. Insights Oncol. 2019;13:1179554918825449. Epub 2019\/02\/08. doi: 10.1177\/1179554918825449. PubMed PMID: 30728735; PubMed Central PMCID: PMCPMC6351720.","DOI":"10.1177\/1179554918825449"},{"issue":"23","key":"10.1016\/j.bioelechem.2022.108287_b0060","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.bioelechem.2022.108287_b0065","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bioelechem.2022.108287_b0070","doi-asserted-by":"crossref","unstructured":"M.E. Lacouture, M.E. Davis, G. Elzinga, N. Butowski, D. Tran, J.L. Villano, et al. Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma. Semin Oncol. 2014;41 Suppl 4:S1-Epub 2014\/05\/06. doi: 10.1053\/j.seminoncol.2014.03.011. PubMed PMID: 24794308.","DOI":"10.1053\/j.seminoncol.2014.03.011"},{"key":"10.1016\/j.bioelechem.2022.108287_b0075","doi-asserted-by":"crossref","unstructured":"M.E. Lacouture, M.J. Anadkat, M.T. Ballo, F. Iwamoto, S.A. Jeyapalan, R.V. La Rocca, et al., Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma, Front Oncol. 2020;10:1045. Epub 2020\/08\/28. doi: 10.3389\/fonc.2020.01045. PubMed PMID: 32850308; PubMed Central PMCID: PMCPMC7399624.","DOI":"10.3389\/fonc.2020.01045"},{"issue":"4","key":"10.1016\/j.bioelechem.2022.108287_b0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2017.5082","article-title":"Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial","volume":"4","author":"Taphoorn","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0085","article-title":"Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)","volume":"123","author":"Porat","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-018-2858-9","article-title":"Acceptance and compliance of TTFields treatment among high grade glioma patients","volume":"139","author":"Onken","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0095","doi-asserted-by":"crossref","unstructured":"C. Cobbs, E. McClay, J.P. Duic, L.B. Nabors, D. Morgan Murray, S. Kesari, An early feasibility study of the Nativis Voyager((R)) device in patients with recurrent glioblastoma: first cohort in US, CNS Oncol. 2019;8(1):CNS30. Epub 2018\/12\/15. doi: 10.2217\/cns-2018-0013. PubMed PMID: 30547676; PubMed Central PMCID: PMCPMC6499016.","DOI":"10.2217\/cns-2018-0013"},{"key":"10.1016\/j.bioelechem.2022.108287_b0100","doi-asserted-by":"crossref","unstructured":"M. Murphy, A. Dowling, C. Thien, E. Priest, D. Morgan Murray, S. Kesari, A feasibility study of the Nativis Voyager((R)) device in patients with recurrent glioblastoma in Australia. CNS Oncol. 2019;8(1):CNS31. Epub 2019\/02\/08. doi: 10.2217\/cns-2018-0017. PubMed PMID: 30727742; PubMed Central PMCID: PMCPMC6499017.","DOI":"10.2217\/cns-2018-0017"},{"key":"10.1016\/j.bioelechem.2022.108287_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708017","article-title":"Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device","volume":"11","author":"Baskin","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108287_b0110","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S1470-2045(19)30532-7","article-title":"Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial","volume":"20","author":"Ceresoli","year":"2019","journal-title":"Lancet Oncol."},{"issue":"14","key":"10.1016\/j.bioelechem.2022.108287_b0115","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bioelechem.2022.108287_b0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1521-186X(1997)18:8<563::AID-BEM5>3.0.CO;2-0","article-title":"Summary of measured radiofrequency electric and magnetic fields(10 kHz to 30 GHz) in the general and work environment","volume":"18","author":"Mantiply","year":"1997","journal-title":"Bioelectromagnetics."},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/HP.0b013e31822f8e39","article-title":"Assessment of RF exposures from emerging wireless communication technologies in different environments","volume":"102","author":"Joseph","year":"2012","journal-title":"Health Phys."},{"key":"10.1016\/j.bioelechem.2022.108287_b0130","doi-asserted-by":"crossref","unstructured":"D. Gombarska, M. Smetana, L. Janousek, High-frequency Electromagnetic Field Measurement inside Personal Vehicle within Urban Environment, 2019 Proceedings of the 12th International Conference on Measurement (Measurement 2019). 2019:223-6. PubMed PMID: WOS:000502830700049.","DOI":"10.23919\/MEASUREMENT47340.2019.8779929"},{"key":"10.1016\/j.bioelechem.2022.108287_b0135","unstructured":"A.Y. Te\u015fneli, N.B. Te\u015fneli, Measurements of Electromagnetic Radiation in an urban environment, 6th International Workshop on Biological Effects of Electromagnetic Fields; Bodrum, Turkey, 2010."},{"key":"10.1016\/j.bioelechem.2022.108287_b0140","doi-asserted-by":"crossref","unstructured":"D.J. Panagopoulos, O. Johansson, G.L. Carlo, Evaluation of specific absorption rate as a dosimetric quantity for electromagnetic fields bioeffects, PLoS One 2013;8(6):e62663. Epub 2013\/06\/12. doi: 10.1371\/journal.pone.0062663. PubMed PMID: 23750202; PubMed Central PMCID: PMCPMC3672148.","DOI":"10.1371\/journal.pone.0062663"},{"issue":"5","key":"10.1016\/j.bioelechem.2022.108287_b0145","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ijrobp.2015.11.042","article-title":"Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts","volume":"94","author":"Wenger","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.bioelechem.2022.108287_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13111128","article-title":"An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields","volume":"13","author":"Tuszynski","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bioelechem.2022.108287_b0155","doi-asserted-by":"crossref","unstructured":"M.A. Stuchly, Interaction of radiofrequency and microwave radiation with living systems. A review of mechanisms, Radiat. Environ. Biophys. 1979;16(1):1-14. Epub 1979\/02\/23. doi: 10.1007\/BF01326892. PubMed PMID: 382232.","DOI":"10.1007\/BF01326892"},{"key":"10.1016\/j.bioelechem.2022.108287_b0160","unstructured":"IEEE Standard for Safety Levels with Respect to Human Exposure to Electric, Magnetic, and Electromagnetic Fields, 0 Hz to 300 GHz. IEEE C951-2019 [Internet]. 2019; IEEE C95.1-2019."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0165","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1038\/s41598-019-43621-9","article-title":"Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase\/cytokinesis","volume":"9","author":"Berkelmann","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010110","article-title":"Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells","volume":"11","author":"Neuhaus","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"25","key":"10.1016\/j.bioelechem.2022.108287_b0175","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1016\/j.biomaterials.2014.04.077","article-title":"Mechanical properties and biocompatibility of melt processed, self-reinforced ultrahigh molecular weight polyethylene","volume":"35","author":"Huang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioelechem.2022.108287_b0180","doi-asserted-by":"crossref","unstructured":"D.F. Williams, There is no such thing as a biocompatible material, Biomaterials 2014;35(38):10009-14. Epub 2014\/09\/30. doi: 10.1016\/j.biomaterials.2014.08.035. PubMed PMID: 25263686.","DOI":"10.1016\/j.biomaterials.2014.08.035"},{"issue":"9","key":"10.1016\/j.bioelechem.2022.108287_b0185","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioelechem.2022.108287_b0190","unstructured":"Directive 2006\/95\/EC of the European Parliament and of the Council of 12 December 2006 on the harmonisation of the laws of Member States relating to electrical equipment designed for use within certain voltage limits (codified version) (Text with EEA relevance). European Union [Internet]. 2016. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=CELEX%3A32006L0095."},{"key":"10.1016\/j.bioelechem.2022.108287_b0195","unstructured":"IEC 61140:2016 Protection against electric shock - Common aspects for installation and equipment. International Electrotechnical Commission [Internet]. 2016. Available from: https:\/\/webstore.iec.ch\/publication\/23997."},{"issue":"24","key":"10.1016\/j.bioelechem.2022.108287_b0200","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.0702916104","article-title":"Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors","volume":"104","author":"Kirson","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioelechem.2022.108287_b0205","doi-asserted-by":"crossref","unstructured":"M.H. Megherhi, J.P. Dougherty, G.O. Dayton, R.E. Newnham, Electrical properties of co-fired high and low dielectric constant multilayer package materials, Proceedings of the 1990 IEEE 7th International Symposium on Applications of Ferroelectrics. 1990:31-5. doi: 10.1109\/ISAF.1990.200194.","DOI":"10.1109\/ISAF.1990.200194"},{"issue":"5","key":"10.1016\/j.bioelechem.2022.108287_b0210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.04.008","article-title":"Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial","volume":"104","author":"Ballo","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioelechem.2022.108287_b0215","doi-asserted-by":"crossref","unstructured":"V. Balasubramanian, Brain power, Proc. Natl. Acad. Sci. U. S. A. 2021;118(32). doi: 10.1073\/pnas.2107022118. PubMed PMID: 34341108; PubMed Central PMCID: PMCPMC8364152.","DOI":"10.1073\/pnas.2107022118"},{"issue":"11","key":"10.1016\/j.bioelechem.2022.108287_b0220","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/cns.13441","article-title":"Evaluation of a tumor electric field treatment system in a rat model of glioma","volume":"26","author":"Wu","year":"2020","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.bioelechem.2022.108287_b0225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10585-009-9262-y","article-title":"Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs","volume":"26","author":"Kirson","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bioelechem.2022.108287_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-018-0106-x","article-title":"Selective toxicity of tumor treating fields to melanoma: an in vitro and in vivo study","volume":"4","author":"Jo","year":"2018","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.bioelechem.2022.108287_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113684","article-title":"Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy","volume":"19","author":"Jo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioelechem.2022.108287_b0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bioelechem.2015.04.006","article-title":"Tumor growth delay by adjuvant alternating electric fields which appears non-thermally mediated","volume":"105","author":"Castellvi","year":"2015","journal-title":"Bioelectrochemistry"},{"issue":"11","key":"10.1016\/j.bioelechem.2022.108287_b0245","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41419-018-1085-9","article-title":"AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)","volume":"9","author":"Shteingauz","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioelechem.2022.108287_b0250","doi-asserted-by":"crossref","first-page":"18046","DOI":"10.1038\/srep18046","article-title":"Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells","volume":"5","author":"Giladi","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pan.2013.11.009","article-title":"Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields","volume":"14","author":"Giladi","year":"2014","journal-title":"Pancreatology."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13014-017-0941-6","article-title":"Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells","volume":"12","author":"Giladi","year":"2017","journal-title":"Radiat Oncol."},{"issue":"39","key":"10.1016\/j.bioelechem.2022.108287_b0265","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1038\/s41388-019-0882-7","article-title":"Tumor-treating fields induce autophagy by blocking the Akt2\/miR29b axis in glioblastoma cells","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bioelechem.2022.108287_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6649-9-1","article-title":"Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)","volume":"9","author":"Kirson","year":"2009","journal-title":"BMC Med. Phys."},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108287_b0275","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/ijc.30406","article-title":"Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo","volume":"139","author":"Voloshin","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.bioelechem.2022.108287_b0280","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00262-020-02534-7","article-title":"Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy","volume":"69","author":"Voloshin","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bioelechem.2022.108287_b0285","doi-asserted-by":"crossref","unstructured":"M. Giladi, U. Weinberg, R.S. Schneiderman, Y. Porat, M. Munster, T. Voloshin, et al., Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo, Semin. Oncol. 2014;41 Suppl 6:S35-41. Epub 2014\/09\/13. doi: 10.1053\/j.seminoncol.2014.09.006. PubMed PMID: 25213867.","DOI":"10.1053\/j.seminoncol.2014.09.006"},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108287_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121999","article-title":"5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bioelechem.2022.108287_b0295","first-page":"3475","article-title":"Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3","volume":"10","author":"Kim","year":"2020","journal-title":"Am J Cancer Res."},{"key":"10.1016\/j.bioelechem.2022.108287_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.670809","article-title":"In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso","volume":"11","author":"Blatt","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lungcan.2021.08.011","article-title":"Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models","volume":"160","author":"Mumblat","year":"2021","journal-title":"Lung Cancer."},{"key":"10.1016\/j.bioelechem.2022.108287_b0310","doi-asserted-by":"crossref","unstructured":"J. Li, C. Guo, Z. Wang, K. Gao, X. Shi, J. Liu, Electrical stimulation towards melanoma therapy via liquid metal printed electronics on skin, Clin. Transl. Med. 2016;5(1):21. Epub 2016\/06\/25. doi: 10.1186\/s40169-016-0102-9. PubMed PMID: 27339426; PubMed Central PMCID: PMCPMC4919201.","DOI":"10.1186\/s40169-016-0102-9"},{"issue":"8","key":"10.1016\/j.bioelechem.2022.108287_b0315","first-page":"3935","article-title":"Tumor treating fields can effectively overcome trastuzumab resistant breast cancer multiplication","volume":"11","author":"Kim","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bioelechem.2022.108287_b0320","article-title":"The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes","volume":"Epub 2015\/03\/03","author":"Rehman","year":"201538314","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.bioelechem.2022.108287_b0325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1477-7819-12-162","article-title":"The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF-100A system","volume":"12","author":"Turner","year":"2014","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0330","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/s12885-016-2890-0","article-title":"Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement","volume":"16","author":"Connelly","year":"2016","journal-title":"BMC Cancer."},{"key":"#cr-split#-10.1016\/j.bioelechem.2022.108287_b0335.1","doi-asserted-by":"crossref","unstructured":"N. Gentilal, R. Salvador, P.C. Miranda, A Thermal Study of Tumor-Treating Fields for Glioblastoma Therapy, in: Makarov SN, Noetscher GM, Nummenmaa A, editors. Brain and Human Body Modeling 2020: Computational Human Models Presented at EMBC 2019 and the BRAIN Initiative","DOI":"10.1007\/978-3-030-45623-8_3"},{"key":"#cr-split#-10.1016\/j.bioelechem.2022.108287_b0335.2","unstructured":"(R) 2019 Meeting. Cham (CH)2021. p. 37-62."},{"key":"10.1016\/j.bioelechem.2022.108287_b0340","unstructured":"Pre-Market Approval of Optune (Formerly the NOVOTTF-100A System) US Food and Drug Administration [Internet]. 2015; P100034. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P100034S013."},{"key":"10.1016\/j.bioelechem.2022.108287_b0345","unstructured":"Pre-Market Approval for Optune. US Food and Drug Administration [Internet]. 2016; P100034. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=354374."},{"issue":"3","key":"10.1016\/j.bioelechem.2022.108287_b0350","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3171\/2018.8.SPINE18198","article-title":"Surgical management of spinal meningiomas: focus on unilateral posterior approach and anterior localization","volume":"30","author":"Onken","year":"2018","journal-title":"J. Neurosurg.Spine."},{"key":"10.1016\/j.bioelechem.2022.108287_b0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-018-0130-x","article-title":"Tumor treating fields increases membrane permeability in glioblastoma cells","volume":"4","author":"Chang","year":"2018","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0360","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neo.2020.11.003","article-title":"Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [(18)F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression","volume":"23","author":"Patel","year":"2021","journal-title":"Neoplasia."},{"issue":"4","key":"10.1016\/j.bioelechem.2022.108287_b0365","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.bioelechem.2022.108287_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092283","article-title":"Permeabilizing Cell Membranes with Electric Fields","volume":"13","author":"Aguilar","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108287_b0375","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.bpj.2020.11.002","article-title":"A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue Cultures","volume":"119","author":"Ravin","year":"2020","journal-title":"Biophys. J ."},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1567-5394(01)00117-7","article-title":"The influence of medium conductivity on electropermeabilization and survival of cells in vitro","volume":"54","author":"Pucihar","year":"2001","journal-title":"Bioelectrochemistry"},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0385","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0006-3495(97)78144-X","article-title":"Introducing dielectrophoresis as a new force field for field-flow fractionation","volume":"73","author":"Huang","year":"1997","journal-title":"Biophys. J ."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0390","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bioelechem.2008.06.001","article-title":"Effects of cell orientation and electric field frequency on the transmembrane potential induced in ellipsoidal cells","volume":"74","author":"Maswiwat","year":"2008","journal-title":"Bioelectrochemistry"},{"issue":"3","key":"10.1016\/j.bioelechem.2022.108287_b0395","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0304-4157(82)90007-7","article-title":"Electric field-mediated fusion and related electrical phenomena","volume":"694","author":"Zimmermann","year":"1982","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.bioelechem.2022.108287_b0400","series-title":"The Study of Membrane Electrofusion and Electroporation Mechanisms","author":"Sowers","year":"1989"},{"key":"10.1016\/j.bioelechem.2022.108287_b0405","unstructured":"J. Gimsa, M. Stubbe, Fast electric characterization of biological cells using an old idea of Maxwell, Atlas of Science [Internet]. 2016. Available from: https:\/\/atlasofscience.org\/fast-electric-characterization-of-biological-cells-using-an-old-idea-of-maxwell\/."},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0410","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bpj.2015.06.021","article-title":"Maxwell's mixing equation revisited: characteristic impedance equations for ellipsoidal cells","volume":"109","author":"Stubbe","year":"2015","journal-title":"Biophys. J ."},{"key":"10.1016\/j.bioelechem.2022.108287_b0415","doi-asserted-by":"crossref","unstructured":"K. Kaler, H.A. Pohl, Dynamic Dielectrophoretic Levitation of Living Individual Cells, IEEE Trans. Ind. Appl. 1983;IA-19(6):1089-93. doi: 10.1109\/TIA.1983.4504339.","DOI":"10.1109\/TIA.1983.4504339"},{"issue":"18","key":"10.1016\/j.bioelechem.2022.108287_b0420","article-title":"Electrotherapies for Glioblastoma","volume":"8","author":"Jenkins","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bioelechem.2022.108287_b0425","doi-asserted-by":"crossref","unstructured":"D.S. Clague, E.K. Wheeler, Dielectrophoretic manipulation of macromolecules: the electric field, Phys. Rev. E Stat. Nonlin. Soft Matter. Phys. 2001;64(2 Pt 2):026605. Epub 2001\/08\/11. doi: 10.1103\/PhysRevE.64.026605. PubMed PMID: 11497728.","DOI":"10.1103\/PhysRevE.64.026605"},{"issue":"18","key":"10.1016\/j.bioelechem.2022.108287_b0430","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1088\/0031-9155\/60\/18\/7339","article-title":"The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study","volume":"60","author":"Wenger","year":"2015","journal-title":"Phys. Med. Biol."},{"issue":"217","key":"10.1016\/j.bioelechem.2022.108287_b0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2019.10.003","article-title":"Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy","volume":"Epub 2019\/11\/11","author":"Karanam","year":"2020","journal-title":"Transl Res."},{"key":"10.1016\/j.bioelechem.2022.108287_b0440","doi-asserted-by":"crossref","unstructured":"N.K. Karanam, K. Srinivasan, L. Ding, B. Sishc, D. Saha, M.D. Story, Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines, Cell Death Dis. 2017;8(3):e2711. Epub 2017\/03\/31. doi: 10.1038\/cddis.2017.136. PubMed PMID: 28358361; PubMed Central PMCID: PMCPMC5386539.","DOI":"10.1038\/cddis.2017.136"},{"key":"10.1016\/j.bioelechem.2022.108287_b0445","first-page":"6892","article-title":"Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase","volume":"2015","author":"Wenger","year":"2015","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc."},{"issue":"15_suppl","key":"10.1016\/j.bioelechem.2022.108287_b0450","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.e22134","article-title":"Overcoming cell size escape from tumor treating fields using a varying frequency treatment paradigm in vitro","volume":"31","author":"Schneiderman","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0455","doi-asserted-by":"crossref","unstructured":"L. Sabat, C.K. Kundu, History of Finite Element Method: A Review. In: Das BB, Barbhuiya S, Gupta R, Saha P, editors. Recent Developments in Sustainable Infrastructure. 75. Ames, IA: Springer; 2020. p. 395-404.","DOI":"10.1007\/978-981-15-4577-1_32"},{"key":"10.1016\/j.bioelechem.2022.108287_b0460","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2528\/PIER20061002","article-title":"Fundamental Implicit FDTD Schemes for Computational Electromagnetics and Educational Mobile Apps","volume":"168","author":"Tan","year":"2020","journal-title":"Progress In Electromagnetics Research."},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108287_b0465","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1109\/TBME.2020.2983653","article-title":"Impact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study","volume":"67","author":"Lang","year":"2020","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.bioelechem.2022.108287_b0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179214","article-title":"Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study","volume":"12","author":"Korshoej","year":"2017","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.bioelechem.2022.108287_b0475","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/cam4.1095","article-title":"Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma","volume":"6","author":"Lok","year":"2017","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-020-03406-x","article-title":"Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma","volume":"147","author":"Lok","year":"2020","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0485","unstructured":"Y.S. Sun, Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study, Comput. Math. Methods Med. 2018;2018:3829768. Epub 2018\/04\/24. doi: 10.1155\/2018\/3829768. PubMed PMID: 29681995; PubMed Central PMCID: PMCPMC5842745."},{"key":"10.1016\/j.bioelechem.2022.108287_b0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cobme.2018.09.002","article-title":"Realistic modeling of transcranial current stimulation: The electric field in the brain","volume":"8","author":"Miranda","year":"2018","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.bioelechem.2022.108287_b0495","doi-asserted-by":"crossref","unstructured":"C. Wenger, Z. Bomzon, R. Salvador, P.J. Basser, P.C. Miranda, Simplified realistic human head model for simulating Tumor Treating Fields (TTFields). Annu Int Conf IEEE Eng Med Biol Soc. 2016;2016:5664-7. Epub 2017\/03\/09. doi: 10.1109\/EMBC.2016.7592012. PubMed PMID: 28269540.","DOI":"10.1109\/EMBC.2016.7592012"},{"key":"10.1016\/j.bioelechem.2022.108287_b0500","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1109\/RBME.2017.2765282","article-title":"A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling","volume":"11","author":"Wenger","year":"2018","journal-title":"IEEE Rev. Biomed. Eng."},{"issue":"15","key":"10.1016\/j.bioelechem.2022.108287_b0505","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1088\/0031-9155\/59\/15\/4137","article-title":"Predicting the electric field distribution in the brain for the treatment of glioblastoma","volume":"59","author":"Miranda","year":"2014","journal-title":"Phys. Med. Biol."},{"issue":"43","key":"10.1016\/j.bioelechem.2022.108287_b0510","doi-asserted-by":"crossref","first-page":"26546","DOI":"10.1039\/C7RA01906H","article-title":"Power loss density of electromagnetic waves in unimolecular reactions","volume":"7","author":"Liao","year":"2017","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bioelechem.2022.108287_b0515","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aafe54","article-title":"Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy","volume":"64","author":"Korshoej","year":"2019","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0520","first-page":"4897","article-title":"Estimating the Intensity and Anisotropy of Tumor Treating Fields Jsing Singular Value Decomposition. Towards a More Comprehensive Estimation of Anti-tumor Efficacy. Annu Int Conf IEEE Eng Med","author":"Korshoej","year":"2018","journal-title":"Biol Soc."},{"issue":"5","key":"10.1016\/j.bioelechem.2022.108287_b0525","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ijrobp.2021.12.152","article-title":"The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns","volume":"112","author":"Glas","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioelechem.2022.108287_b0530","doi-asserted-by":"crossref","unstructured":"A.R. Korshoej, F.L. Hansen, N. Mikic, G. von Oettingen, J.C.H. Sorensen, A. Thielscher, Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations, PLoS One 2018;13(8):e0201957. Epub 2018\/08\/23. doi: 10.1371\/journal.pone.0201957. PubMed PMID: 30133493; PubMed Central PMCID: PMC6104980.","DOI":"10.1371\/journal.pone.0201957"},{"issue":"10","key":"10.1016\/j.bioelechem.2022.108287_b0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164051","article-title":"Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study","volume":"11","author":"Korshoej","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0540","article-title":"OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma","volume":"2","author":"Korshoej","year":"2020","journal-title":"Neurooncol Adv."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0545","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12885-021-08709-4","article-title":"Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial","volume":"21","author":"Mikic","year":"2021","journal-title":"BMC Cancer."},{"key":"10.1016\/j.bioelechem.2022.108287_b0550","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac047","article-title":"Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])","author":"Shams","year":"2022","journal-title":"J. Molec. Cell Biol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0555","article-title":"Synergism between chemotherapy and alternating electric fields (TTFields) in cancer cell proliferation inhibition and solid tumor treatment","author":"Schneiderman","year":"2008","journal-title":"AACR"},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0560","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11060-017-2534-5","article-title":"Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields","volume":"134","author":"Chang","year":"2017","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.bioelechem.2022.108287_b0565","doi-asserted-by":"crossref","unstructured":"D. Lavie, E. Glotter, Y. Shvo, 1371. Constituents of Withania somnifera Dun. Part IV. The structure of withaferin A, J. Chem. Soc. (Resumed). 1965:7517-31.","DOI":"10.1039\/jr9650007517"},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0570","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/acs.analchem.7b03859","article-title":"Characterizing Deformability and Electrical Impedance of Cancer Cells in a Microfluidic Device","volume":"90","author":"Zhou","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bioelechem.2022.108287_b0575","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jelechem.2018.06.021","article-title":"Distinguishing skin cancer cells and normal cells using electrical impedance spectroscopy","volume":"823","author":"Zhang","year":"2018","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.bioelechem.2022.108287_b0580","doi-asserted-by":"crossref","first-page":"25979","DOI":"10.1109\/ACCESS.2018.2830883","article-title":"Electrical Characterization of Normal and Cancer Cells","volume":"6","author":"Al Ahmad","year":"2018","journal-title":"IEEE Access"},{"key":"10.1016\/j.bioelechem.2022.108287_b0585","doi-asserted-by":"crossref","unstructured":"X. Li, M. Oziel, B. Rubinsky, Evaluating the therapeutic effect of tumor treating fields (TTFields) by monitoring the impedance across TTFields electrode arrays, PeerJ, 2022;10:e12877. Epub 2022\/02\/22. doi: 10.7717\/peerj.12877. PubMed PMID: 35186474; PubMed Central PMCID: PMCPMC8833244.","DOI":"10.7717\/peerj.12877"},{"issue":"2","key":"10.1016\/j.bioelechem.2022.108287_b0590","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuroimage.2008.07.023","article-title":"Use of anisotropic modelling in electrical impedance tomography: description of method and preliminary assessment of utility in imaging brain function in the adult human head","volume":"43","author":"Abascal","year":"2008","journal-title":"Neuroimage."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108287_b0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170563","article-title":"The Frequency Spectral Properties of Electrode-Skin Contact Impedance on Human Head and Its Frequency-Dependent Effects on Frequency-Difference EIT in Stroke Detection from 10Hz to 1MHz","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.bioelechem.2022.108287_b0600","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s10439-018-02189-7","article-title":"The Resistivity of Human Brain Tumours In Vivo","volume":"47","author":"Latikka","year":"2019","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.bioelechem.2022.108287_b0605","unstructured":"M. Krinitsky, Y. Wasserman, M. Shtotland, S. Davidi, R. Blat, G.B. Tal, et al., inventors; Novocure Ltd., assignee. Swivel assembly for actively limiting torsion of a cable, and systems and methods of using same. Provisional Patent Application Document ID US 20210185976 A1. U.S. Patent and Trademark Office. 2021 (Patent Pending)."},{"key":"10.1016\/j.bioelechem.2022.108287_b0610","unstructured":"S. Strauss, Y. Wasserman, S. Davidi, R. Blat, G.B. Tal, M. Giladi, et al., inventors; Novocure Ltd., assignee. Cage assembly for animal test subjects. Provisional Patent Application Document ID US 20210185975 A1. U.S. Patent and Trademark Office. 2021 (Patent Pending)."},{"key":"10.1016\/j.bioelechem.2022.108287_b0615","unstructured":"M. Munster, Y. Wasserman, M. Shtotland, S. Davidi, R. Blat, G.B. Tal, et al., inventors; Novocure Ltd., assignee. Treatment assembly for providing tumor treating fields to animal test subjects. Provisional Patent Application Document ID US 20210187289 A1. U.S. Patent and Trademark Office. 2021 (Patent Pending)."},{"issue":"9","key":"10.1016\/j.bioelechem.2022.108287_b0620","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1109\/TPEL.2013.2249670","article-title":"A critical review of recent progress in mid-range wireless power transfer","volume":"29","author":"Hui","year":"2013","journal-title":"IEEE Trans. Power Electron."},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108287_b0625","doi-asserted-by":"crossref","DOI":"10.3390\/s20123487","article-title":"Wireless Power Transfer Techniques for Implantable Medical Devices: A Review","volume":"20","author":"Khan","year":"2020","journal-title":"Sensors (Basel)"}],"container-title":["Bioelectrochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567539422002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567539422002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:57:41Z","timestamp":1761584261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567539422002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":126,"alternative-id":["S1567539422002389"],"URL":"https:\/\/doi.org\/10.1016\/j.bioelechem.2022.108287","relation":{},"ISSN":["1567-5394"],"issn-type":[{"value":"1567-5394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioelectrochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioelechem.2022.108287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108287"}}